CVS vs CI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CVS

38.8
AI Score
VS
CVS Wins

CI

26.6
AI Score

Investment Advisor Scores

CVS

39score
Recommendation
AVOID NEW MONEY

CI

27score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS CI Winner
Forward P/E 10.6724 8.2576 CI
PEG Ratio 0.2113 0.7509 CVS
Revenue Growth 7.1% 6.7% CVS
Earnings Growth 188.8% 10.2% CVS
Tradestie Score 38.8/100 26.6/100 CVS
Profit Margin 1.2% 2.3% CI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CVS 1M: +10.0% · 3M: -12.3% CI 1M: +17.7% · 3M: +9.1%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.5 · Price: $94.48

CI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 75

RSI (14): 75.0 · Price: $315.88

Fundamentals Snapshot

Metric CVS CI
Market Cap — —
Forward P/E 11.1 9.4
Trailing P/E 24.6 12.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 3.80 24.19
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.